Bibi Sattar Marques
Partner & Board Member @ Buenavista Equity Partners Portugal
Lisbon, Portugal
Bibi Sattar Marques is a seed investor at Buenavista Equity Partners Portugal in Lisbon focused on Health Care and Biotechnology. Bibi Sattar Marques is partner at GED Ventures Portugal.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 83%
Last updated:
For AI agents: llms.txt
Industries Bibi Sattar Marques invests in
Stages Bibi Sattar Marques invests in
Countries Bibi Sattar Marques invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 4 (67%)
- Biotechnology 2 (33%)
- Apps 1 (17%)
- Fitness 1 (17%)
- Medical 1 (17%)
Stage
- Seed 3 (50%)
- Venture - Series Unknown 2 (33%)
- Series B 1 (17%)
Country
- Portugal 3 (50%)
- Germany 1 (17%)
- Switzerland 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Medyria is a Swiss medtech startup that engineers technologies for cardiovascular catheter navigation and sensing. They develop a unique guiding and sensing medical device based on proprietary Blood Flow Velocity Sensor technology. The TrackCath System is designed to be cost-effective and safe during EVAR procedures.Medyria's goal is todevelop devices that enable safer and more effective endovascular procedures. It was founded in 2014 and is based in Winterthur, Zurich, Switzerland. | $1.9M / Venture - Series Unknown / Jul 16, 2025 | ||
| A disruptive startup developing human milk proteins as alternative proteins by precision fermentation. | $2.9M / Seed / Jun 06, 2025 | ||
| CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries. | $10.8M / Series B / Apr 02, 2024 | ||
| Hope Care is a digital health company that combines services, products, and cutting-edge technology platforms to enable the delivery of Social and Health Care without barriers. | Venture - Series Unknown / Nov 10, 2023 | ||
| NU-RISE LDA helping doctors provide better cancer treatment. They have developed a probe that goes inside the body. This probe will monitor, in real-time, the level of radiation the patient is receiving. The Doctor can target the cancer but avoid the healthy organs. Better, safer and more accurate radiation - it's an evolution for cancertreatment. | $3.5M / Seed / Mar 04, 2023 | ||
| Virtuleap combines neuroscience and virtual reality to help increase attention levels, and address cognitive illnesses, disorders, and learning challenges. We have created a library of VR games designed by neuroscientists in order to test and train a range of cognitive abilities and make that data accessible through our enterprise platform. Ourfirst paid client is the AARP, and we are now working with leading institutions, like the VA Health Care System and the Pacific Brain Health Center, to validate our solution as an effective diagnostic and treatment for attention deficit and cognitive decline. | $3.3M / Seed / Jan 01, 2023 |
Co-Investors
#Tech4Purpose – Investing in innovative, global and purpose-driven ESG-friendly ethos technologies
Buenavista Equity Partners Portugal Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Bibi Sattar Marques
Partner & Board Member
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Bibi Sattar Marques invest in?
Bibi Sattar Marques invests primarily in Health Care, Biotechnology and Apps startups, most often at Seed and Venture - Series Unknown stage. Most of the 6 investments tracked by Shizune back companies in Portugal. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Bibi Sattar Marques?
Public channels for Bibi Sattar Marques include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Bibi Sattar Marques last invest?
The most recent investment recorded for Bibi Sattar Marques closed in Jul 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
